300 related articles for article (PubMed ID: 31357627)
1. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy.
Cascella R; Fani G; Capitini C; Rusmini P; Poletti A; Cecchi C; Chiti F
FASEB J; 2017 Dec; 31(12):5609-5624. PubMed ID: 28842427
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and mis-metabolism of the neuropathological signature protein TDP-43.
Huang CC; Bose JK; Majumder P; Lee KH; Huang JT; Huang JK; Shen CK
J Cell Sci; 2014 Jul; 127(Pt 14):3024-38. PubMed ID: 24860144
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species.
Scotter EL; Vance C; Nishimura AL; Lee YB; Chen HJ; Urwin H; Sardone V; Mitchell JC; Rogelj B; Rubinsztein DC; Shaw CE
J Cell Sci; 2014 Mar; 127(Pt 6):1263-78. PubMed ID: 24424030
[TBL] [Abstract][Full Text] [Related]
6. Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells.
Cicardi ME; Cristofani R; Rusmini P; Meroni M; Ferrari V; Vezzoli G; Tedesco B; Piccolella M; Messi E; Galbiati M; Boncoraglio A; Carra S; Crippa V; Poletti A
Sci Rep; 2018 Aug; 8(1):12390. PubMed ID: 30120266
[TBL] [Abstract][Full Text] [Related]
7. Zinc induces depletion and aggregation of endogenous TDP-43.
Caragounis A; Price KA; Soon CP; Filiz G; Masters CL; Li QX; Crouch PJ; White AR
Free Radic Biol Med; 2010 May; 48(9):1152-61. PubMed ID: 20138212
[TBL] [Abstract][Full Text] [Related]
8. Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases.
Huang C; Yan S; Zhang Z
Transl Neurodegener; 2020 Oct; 9(1):40. PubMed ID: 33126923
[TBL] [Abstract][Full Text] [Related]
9. Znf179 E3 ligase-mediated TDP-43 polyubiquitination is involved in TDP-43- ubiquitinated inclusions (UBI) (+)-related neurodegenerative pathology.
Lee YC; Huang WC; Lin JH; Kao TJ; Lin HC; Lee KH; Lin HC; Shen CJ; Chang WC; Huang CC
J Biomed Sci; 2018 Nov; 25(1):76. PubMed ID: 30404641
[TBL] [Abstract][Full Text] [Related]
10. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
11. Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera.
Tseng YL; Lu PC; Lee CC; He RY; Huang YA; Tseng YC; Cheng TR; Huang JJ; Fang JM
J Biomed Sci; 2023 Apr; 30(1):27. PubMed ID: 37101169
[TBL] [Abstract][Full Text] [Related]
12. TAR DNA-binding protein 43 in neurodegenerative disease.
Chen-Plotkin AS; Lee VM; Trojanowski JQ
Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
[TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.
Li HY; Yeh PA; Chiu HC; Tang CY; Tu BP
PLoS One; 2011; 6(8):e23075. PubMed ID: 21850253
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.
Nonaka T; Arai T; Buratti E; Baralle FE; Akiyama H; Hasegawa M
FEBS Lett; 2009 Jan; 583(2):394-400. PubMed ID: 19111550
[TBL] [Abstract][Full Text] [Related]
15. Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43.
Caccamo A; Shaw DM; Guarino F; Messina A; Walker AW; Oddo S
Hum Mol Genet; 2015 Aug; 24(16):4625-35. PubMed ID: 26002100
[TBL] [Abstract][Full Text] [Related]
16. CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS.
Uchida T; Tamaki Y; Ayaki T; Shodai A; Kaji S; Morimura T; Banno Y; Nishitsuji K; Sakashita N; Maki T; Yamashita H; Ito H; Takahashi R; Urushitani M
Sci Rep; 2016 Jan; 6():19118. PubMed ID: 26751167
[TBL] [Abstract][Full Text] [Related]
17. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging.
Ishii T; Kawakami E; Endo K; Misawa H; Watabe K
PLoS One; 2017; 12(6):e0179375. PubMed ID: 28599005
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.
Chang CF; Lee YC; Lee KH; Lin HC; Chen CL; Shen CJ; Huang CC
J Biomed Sci; 2016 Oct; 23(1):72. PubMed ID: 27769241
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial protein import regulates cytosolic protein homeostasis and neuronal integrity.
Liu W; Duan X; Fang X; Shang W; Tong C
Autophagy; 2018; 14(8):1293-1309. PubMed ID: 29909722
[TBL] [Abstract][Full Text] [Related]
20. TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.
Lanznaster D; Bourgeais J; Bruno C; Hergesheimer RC; Thepault RA; Vourc'h P; Corcia P; Andres CR; Herault O; Blasco H
Cells; 2019 Dec; 9(1):. PubMed ID: 31888078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
